Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Reprod Med. 2011 Nov;29(6):540-7. doi: 10.1055/s-0031-1293207. Epub 2011 Dec 8.

Testing for inherited thrombophilia in recurrent miscarriage.

Author information

1
Department of Vascular Medicine, Center for Reproductive Medicine, Academic Medical Center, Amsterdam, The Netherlands. p.g.dejong@amc.uva.nl

Abstract

Approximately 1-5% of women trying to conceive experience recurrent miscarriage, and in 50% of these women, the cause of the preceding miscarriages is unknown. Inherited thrombophilias such as factor V Leiden mutation, prothrombin gene mutation (PT 20210A), and deficiencies of natural anticoagulants protein C, protein S, and antithrombin are associated with recurrent miscarriage. Knowledge of the association between inherited thrombophilia and recurrent miscarriage and of potential treatment options for improving chances of a live birth could tempt physicians to test for inherited thrombophilia in women with recurrent miscarriage. However, the strength of the association between inherited thrombophilia and recurrent miscarriage is not very strong, and more importantly, no evidence indicates that the use of anticoagulants improves the chance of live birth in these women. With the current state of evidence, testing for inherited thrombophilia should not lead to altered clinical management and therefore, should not be performed routinely in women with recurrent miscarriage but only in the context of scientific studies.

PMID:
22161466
DOI:
10.1055/s-0031-1293207
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Support Center